Jcog9205
Web1 gen 2003 · Cancer: The Japan Clinical Oncology Group Study (JCOG9205) By Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, Narikazu Boku, Ichinosuke Hyodo, Hiroshi … Web26 ott 2013 · Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology …
Jcog9205
Did you know?
WebHis study connects Placebo and Internal medicine. Atsushi Ohtsu combines subjects such as Regimen, Irinotecan and Clinical trial with his study of Oncology. Many of his studies involve connections with topics such as Esophageal cancer and Surgery. His Cancer study combines topics in areas such as Cancer research, Pharmacology and Pathology. WebBackground: Two randomized phase III trials of first-line chemotherapy for advanced gastric cancer (JCOG9205 and JCOG9912) conducted by the Japan Clinical Oncology Group …
Web28 set 2024 · Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, et al. Studio randomizzato di fase III di fluorouracile da solo contro fluorouracile più cisplatino contro uracile e tegafur più mitomicina in pazienti con carcinoma gastrico avanzato non resecabile: il Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol. 2003 Jan;21(1):54-9. Web1 nov 2006 · Advanced gastric cancer patients were randomly assigned to docetaxel 75 mg/m2 and cisplatin 75 mg/m2 (day 1) plus fluorouracil 750 mg/m2/d (days 1 to 5) every 3 weeks or cisplatin 100 mg/m2 (day 1) plus fluorouracil 1,000 mg/m2/d (days 1 to 5) every 4 weeks. The primary end point was time-to-progression (TTP).
WebAbstract. The Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (GIOSG/JCOG) has conducted several clinical trials to establish standard chemotherapy for unresectable or recurrent gastric cancer. From the late 1980s to early 1990s, two phase II studies by JCOG evaluated oral fluoropyrimidines, and others introduced Western ... Web28 mar 2013 · Cisplatin (CDDP) is one of the most efficacious and widely used cytotoxic anticancer drugs used for the treatment of numerous types of cancer. However, its efficacy is limited as a result of acquired drug resistance. AKT overexpression may provide a potential mechanism leading to the resistance of human gastric cancer cells; however, …
Web26 ott 2013 · Background Two randomized phase III trials of first-line chemotherapy for advanced gastric cancer (JCOG9205 and JCOG9912) conducted by the Japan Clinical …
Web1 gen 2002 · However, the choice of methodology did influence these estimates in the one trial whose data had not been managed periodically during the trial period (JCOG9205). … crysto panda\\u0027s wifeWeb20 ago 2010 · Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). dynamics finance operations dataverseWeb14 dic 2011 · Systemic chemotherapy is the key treatment for patients presenting with advanced gastric cancer with peritoneal dissemination. In certain cases, adjuvant surgery following systemic chemotherapy may result in improved long-term survival. This study aimed to evaluate the efficacy of adjuvant surgery following response to … dynamics finance and operations odataWebRandomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The … crystop crystal chandelierWeb27 giu 2024 · Other Recommended Regimens. Capecitabine + Paclitaxel. (Category 2B) 22,23,a,b,h. Days 1-5: Capecitabine 625-825mg/m 2 orally twice daily. Day 1: Paclitaxel 45-50mg/m 2 IV over 1 hour. Repeat ... dynamics financialsWeb3 dic 2010 · Background Although S-1 is effective against advanced gastric cancer (AGC), its efficacy in elderly patients has not yet been investigated sufficiently. We assessed the efficacy and safety of S-1 monotherapy in elderly patients with AGC. Methods We conducted a retrospective review of the data of 153 patients with unresectable/recurrent gastric … crysto panda x sheebahWebCancer: The Japan Clinical Oncology Group Study (JCOG9205) By Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, Narikazu Boku, Ichinosuke Hyodo, Hiroshi Saito, Noboru Yamamichi, dynamics field service work order type